本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Oncolytics Biotech Inc

0.5700
+0.01382.48%
盘后0.57000.00000.00%18:13 EDT
成交量:43.55万
成交额:24.75万
市值:4,936.25万
市盈率:-1.98
高:0.5867
开:0.5800
低:0.5556
收:0.5562
数据加载中...
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/28

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/11

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/02/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/12/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2018/11/09

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]